PLASMAFLO OP OP-05W

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-12-27 for PLASMAFLO OP OP-05W manufactured by Asahi Kasei Medical Co., Ltd..

Event Text Entries

[95799879] This incident occurred in (b)(6) and we are reporting this event since we consider the severity of the event is serious injury as the patient experienced shock and causal relationship between this device and the event could not be denied because the event happened during the treatment. The root cause could not be identified. The adverse event may have been caused by clinical condition of the patient. We are unable to investigate since the actual used medical device was not returned to us and the lot number was unknown.
Patient Sequence No: 1, Text Type: N, H10


[95799880] In (b)(6) 2017, the patient was given the treatment with immunoadsorption plasmapheresis with plasma separator (plasmaflo op). At the beginning of the treatment, the systolic blood pressure decreased from 110 mmhg to 90 mmhg and the lower extremities were elevated for the intervention. The treatment was restarted at 15% of the plasma separator flow rate. Since the systolic blood pressure was able to maintain between 100 to 110mmhg at this flow rate for an hour, the plasma separator flow rate was increased to 18%. After 15 minutes of this increase of the flow rate, the systolic blood pressure was dropped to approximately 80mmhg. When the blood pressure was re-measured, the systolic blood pressure was between 50mmhg to 60mmhg and the heart rate was between 80bpm to 110bpm with atrial fibrillation. The treatment was discontinued and the blood was returned to the patient. The physician was called since the blood pressure did not increase as well as the heart rate was decreased to approximately between 40bpm to 50bpm with bradycardia even though normal saline 100ml via intravenous was administered. After an additional normal saline 200ml and 2ml of ephedrine 1 ample(1ml) diluted with normal saline 10ml were administered, the systolic blood pressure and the heart rate were returned to 120mmhg and 80bpm. The patient went back to the room of the admitted unit after the observation which the systolic blood pressure was recovered to 110mmhg.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010002-2017-00050
MDR Report Key7147178
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-12-27
Date of Report2017-12-07
Date of Event2017-11-09
Date Mfgr Received2017-12-07
Date Added to Maude2017-12-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. AKITAKE YAMASHITA
Manufacturer Street1-105, KANDA JINBOCHO CHIYODA-KU
Manufacturer CityTOKYO, 101-8101
Manufacturer CountryJA
Manufacturer Postal101-8101
Manufacturer Phone32963735
Manufacturer G1ASAHI KASEI MEDICAL MT CORP.
Manufacturer StreetOITA WORKS 2111-2 OAZA SATO, OITA-SHI
Manufacturer CityOITA, 870-0396
Manufacturer CountryJA
Manufacturer Postal Code870-0396
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePLASMAFLO OP
Generic NamePLASMA SEPARATOR
Product CodeMDP
Date Received2017-12-27
Model NumberPLASMAFLO OP
Catalog NumberOP-05W
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerASAHI KASEI MEDICAL CO., LTD.
Manufacturer Address1-105, KANDA JINBOCHO CHIYODA-KU TOKYO, 101-8101 JA 101-8101


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2017-12-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.